| Symbol | INCR |
|---|---|
| Name | INTERCURE LTD |
| Sector | HEALTH CARE |
| Region | Middle East |
| Industry | BIOMED |
| Address | STATE OF THE JEWS 85,KANDUK, HERZLIYA, 4676670, Israel |
| Telephone | 077-4605012 |
| Fax | 09-7680244 |
| info@intercure.com | |
| Website | www.intercure.co |
| Incorporation | Israel |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | TASE;NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001857030 |
| Description | Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. Additional info from NASDAQ: |
Form 6-K/A-correction of the Extraordinary General Meeting of Shareholders date from August 12, 2026 to August 11, 2026
Read moreNIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds
Read moreInterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds
Read moreForm 6-K- InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition
Read moreInterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition
Read more